HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $3 price target.
Wells Fargo Maintains Equal-Weight on Raytheon Technologies, Lowers Price Target to $98
Wells Fargo analyst Matthew Akers maintains Raytheon Technologies (NYSE:RTX) with a Equal-Weight and lowers the price target from $106 to $98.